A 38-year-old patient with unexplained pancytopenia is scheduled for a bone marrow biopsy to evaluate for possible myelodysplastic syndrome. Which nursing intervention is most important to implement before the procedure?

Clinical Context and Rationale

Before any invasive procedure such as a bone marrow biopsy, the nurse's primary responsibility is ensuring patient safety through legal and ethical preparation. A bone marrow biopsy involves penetrating the bone (typically the posterior iliac crest) with a large-bore needle to aspirate liquid marrow and obtain a solid core specimen. This procedure carries risks including bleeding, infection, and pain, and it is performed to diagnose conditions like myelodysplastic syndrome or leukemia when unexplained pancytopenia is present.

Why Informed Consent is the Priority

Verifying that informed consent has been obtained and documented is the most critical pre-procedure nursing intervention. This is a legal and ethical mandate that must be completed before any invasive diagnostic test. The consent process ensures the patient understands the purpose of the biopsy, the steps involved, potential complications (such as bleeding, infection, or pain), and alternative options. Without verified consent, the procedure cannot legally proceed. The nurse acts as a patient advocate by confirming the consent form is signed, dated, and witnessed, and that the patient can verbalize understanding of what will occur.

Analysis of Other Options

Administering prophylactic antibiotics is not a standard pre-procedure intervention for bone marrow biopsy. This procedure is performed under sterile technique, and routine antibiotic prophylaxis is not indicated unless the patient has specific risk factors such as severe neutropenia or a prosthetic joint, which are not mentioned in the scenario. Positioning the patient is an important step but occurs after consent verification and final procedural time-out. The position—typically prone or lateral decubitus for a posterior iliac crest approach—is secondary to ensuring legal preparation. Applying a topical anesthetic is insufficient for the deep bone penetration involved in marrow aspiration; local anesthetic (e.g., lidocaine) is injected by the provider performing the procedure, and this step occurs after consent is confirmed and the patient is positioned.

Pathophysiology and Procedural Connection

In suspected myelodysplastic syndrome or leukemia, the bone marrow biopsy provides definitive diagnostic information by revealing cellular morphology, blast percentages, and cytogenetic abnormalities. The patient with pancytopenia—a reduction in all three blood cell lines (erythrocytes, leukocytes, thrombocytes)—is at heightened risk for bleeding and infection due to thrombocytopenia and neutropenia. This underlying risk reinforces the importance of pre-procedure safety checks, including coagulation studies and platelet count review, but the consent verification remains the foundational step that must precede all others. The procedure itself involves the provider inserting a needle into the bone marrow cavity, aspirating fluid, and obtaining a core sample, which is then sent for pathology review.